YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Change in Serum Concentrations of Interleukin-2 and Interferon-Γ During Treatment of Tuberculosis

dc.authorid Onbasi, Kevser/0000-0003-2230-9263
dc.authorscopusid 6603207856
dc.authorscopusid 6506257445
dc.authorscopusid 6701476667
dc.authorscopusid 56614153200
dc.authorscopusid 23394986900
dc.authorscopusid 24167791600
dc.authorwosid Onbasi, Kevser/Aac-3973-2020
dc.authorwosid Berktaş, Mustafa/Abd-1302-2021
dc.contributor.author Berktas, M
dc.contributor.author Guducuoglu, H
dc.contributor.author Bozkurt, H
dc.contributor.author Onbasi, KT
dc.contributor.author Kurtoglu, MG
dc.contributor.author Andic, S
dc.date.accessioned 2025-05-10T17:38:20Z
dc.date.available 2025-05-10T17:38:20Z
dc.date.issued 2004
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Yuzuncu Yil Univ, Tip Fak, Mikrobiyol Klin Mikrobiyol AD, TR-65200 Van, Turkey; Yuzuncu Yil Univ, Fac Med, Dept Internal Med, TR-65200 Van, Turkey en_US
dc.description Onbasi, Kevser/0000-0003-2230-9263 en_US
dc.description.abstract We aimed to investigate changes in serum concentrations of the cytokines interleukin (IL)-2 and interferon (IFN)-gamma during the clinical course of active tuberculosis, to establish the presence of cellular immunity before and after treatment. Blood samples were taken from 18 patients with active tuberculosis before and 2 months after therapy; IL-2 and IFN-gamma concentrations were evaluated. The mean serum IL-2 concentration before therapy was 164.5 pg/ml (range 12 - 980 pg/ml) and the concentration 2 months after therapy was 92.11 pg/ml (range 1 - 490 pg/ml). The mean serum IFN-gamma concentrations were 10.83 pg/ml (range 1 - 22.2 pg/ml) and 4.64 pg/ml (range 1 - 28.5 pg/ml), respectively. The decrease in concentrations of both cytokines after therapy was statistically significant. Further studies investigating the benefits of adding cytokines to drug treatment for tuberculosis are needed. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.1177/147323000403200313
dc.identifier.endpage 330 en_US
dc.identifier.issn 0300-0605
dc.identifier.issue 3 en_US
dc.identifier.pmid 15174227
dc.identifier.scopus 2-s2.0-2442666715
dc.identifier.scopusquality Q4
dc.identifier.startpage 324 en_US
dc.identifier.uri https://doi.org/10.1177/147323000403200313
dc.identifier.uri https://hdl.handle.net/20.500.14720/14668
dc.identifier.volume 32 en_US
dc.identifier.wos WOS:000221459600013
dc.identifier.wosquality Q4
dc.language.iso en en_US
dc.publisher Cambridge Med Publ en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Cellular Immunity en_US
dc.subject Tuberculosis en_US
dc.subject Cytokines en_US
dc.subject Interferon-Gamma en_US
dc.subject Interleukin-2 en_US
dc.title Change in Serum Concentrations of Interleukin-2 and Interferon-Γ During Treatment of Tuberculosis en_US
dc.type Article en_US

Files